A Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients with Acute Ischaemic Stroke in Asia – CASTA

2009 ◽  
Vol 4 (5) ◽  
pp. 406-412 ◽  
Author(s):  
Z. Hong ◽  
H. Moessler ◽  
N. Bornstein ◽  
M. Brainin ◽  
W.-D. Heiss
Keyword(s):  
Ischaemic Stroke ◽  
Randomized Trial ◽  
Acute Ischaemic Stroke ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

scholarly journals Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial

2019 ◽  
Vol 18 (4) ◽  
pp. 338-347 ◽  
Author(s):  
Andrei V Alexandrov ◽  
Martin Köhrmann ◽  
Lauri Soinne ◽  
Georgios Tsivgoulis ◽  
Andrew D Barreto ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Randomised Controlled

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

The Lancet ◽  
1998 ◽  
Vol 352 (9136) ◽  
pp. 1245-1251 ◽  
Author(s):  
Werner Hacke ◽  
Markku Kaste ◽  
Cesare Fieschi ◽  
Rüdiger von Kummer ◽  
Antoni Davalos ◽  
...  
Keyword(s):  
Thrombolytic Therapy ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Intravenous Alteplase

Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial

2017 ◽  
Vol 16 (3) ◽  
pp. 217-226 ◽  
Author(s):  
Jacob Elkins ◽  
Roland Veltkamp ◽  
Joan Montaner ◽  
S Claiborne Johnston ◽  
Aneesh B Singhal ◽  
...  
Keyword(s):  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document